Horizon Pharma Announces Launch of DUEXIS(R) (Ibuprofen/Famotidine) 800 mg/26.6 mg in the United States - Yahoo! Finance

Links shared publicly online about this topic.

  • 0
    total visits

Horizon Pharma Announces Launch of DUEXIS(R) (Ibuprofen/Famotidine) 800 mg/26.6 mg in the United States - Yahoo! Finance

finance.yahoo.com —

From Yahoo! Finance: DEERFIELD, IL-- - Horizon Pharma, Inc. today announced that DUEXIS® , a proprietary single-tablet combination of ibuprofen and famotidine , is now available to U.S. physicians for the relief of signs and ...

View full resource at finance.yahoo.com

Tags: Pharma, NSAIDs, Ibuprofen, Gaster, Physician

  • Share

Most Recently Shared on December 6, 2011 at 4:12 am By:

Osteoporosis_OW Osteoporosis_OW

Horizon Pharma Announces Launch of DUEXIS(R) (Ibuprofen/Famotidine) 800 mg/26.6 mg in the United States: DEERFIE... http://t.co/jlnJLuZL

4 months ago...

Reply

Retweet

Favorite

Also Shared By:

OrganizedWisdom RA OrganizedWisdom RA

Osteoarthritis OW Osteoarthritis OW

Advertisement